Page 3 of 5
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Figure 5: Characterization of a new intermediate in the DszA-catalyzed reaction. (A) Partial HPLC chromatogram of the
DszA/photoreduced FMN reaction mixture showing the new intermediate (I20.3) eluting at 20.3 min. The peak eluting at 20.1
min corresponds to an impurity present in commercial FMN. (B) Co-elution of I20.3 with synthesized FMN-N5-oxide. (C) UV-
Visible spectra of FMN and FMN-N5-oxide. The I20.3 spectrum was identical to that of FMN-N5-oxide. D) Extracted ion
chromatograms for [M+H] = 473.1 Da demonstrate that I20.3 is present only in the full reaction mixture. E) Exact mass of
I20.3 consistent with the mass expected for FMN-N5-oxide ([M+H] = 473.11 Da). F) Exact mass of I20.3 generated using 18O2
consistent with the mass expected for [18O1]-FMN-N5-oxide ([M+H] = 475.11 Da).
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5D and 5E) and running the DszA reaction in the presence
terial is available free of charge via the Internet at
of 18O2 showed the expected 2 Da mass increase (Figure
5F). Finally, the ratio of FMN consumed to sulfinic acid
formed in a reaction containing stoichiometric amounts of
photoreduced FMN, DszA and dibenzothiophene sulfone
was 1:0.9 consistent with the stoichiometric conversion of
FMN to FMN-N5-oxide during the course of the DszA cata-
lysed reaction (Figure S4).
AUTHOR INFORMATION
Corresponding Author
Our studies on DszA suggest a mechanism involving
initial formation of flavin hydroperoxide from reduced flavin.
This adds to 3 to form the sulfone-stabilized carbanion 13.
Protonation followed by flavin elimination gives 14 and 15.
Flavin mediated peroxide cleavage14,15 would form 16 and
17. The catalytic cycle is then completed by the conversion
of 16 to 4 and 17 to 15 (Figure 4).
ACKNOWLEDGMENT
This research was supported by the Robert A. Welch Foun-
dation (A-0034 to TPB) and by a grant from the National
Institutes of Health (DK44083).
REFERENCES
(1) Soleimani, M.; Bassi, A.; Margaritis, A. Biotechnology
advances 2007, 25, 570.
(2) Gray, K. A.; Pogrebinsky, O. S.; Mrachko, G. T.; Xi, L.;
Monticello, D. J.; Squires, C. H. Nature biotechnology 1996,
14, 1705.
(3) Liu, S.; Zhang, C.; Su, T.; Wei, T.; Zhu, D.; Wang, K.;
Huang, Y.; Dong, Y.; Yin, K.; Xu, S.; Xu, P.; Gu, L. Proteins:
Struct., Funct., Bioinf. 2014, 82, 1708.
(4) Ryerson, C. C.; Ballou, D. P.; Walsh, C. Biochemistry
1982, 21, 2644.
(5) Lee, W. C.; Ohshiro, T.; Matsubara, T.; Izumi, Y.;
Tanokura, M. J. Biol.Chem. 2006, 281, 32534.
(6) Aida, T.; Squires, T. G.; Venier, C. G. Tetrahedron Lett.
1983, 24, 3543.
(7) Rossi, R. A.; Pierini, A. B.; Penenory, A. B. Chem. Rev.
(Washington, DC, U. S.) 2003, 103, 71.
Decades ago flavin-N5-oxide 17 was considered as an
intermediate in flavin-dependent oxygenase chemistry but
was almost entirely replaced by the flavin hydroperoxide
mechanistic paradigm.11,12 Since FMN-N5-oxide and organ-
ic peroxides are easily reduced by widely used biochemical
reducing agents, (DTT, TCEP, NADH etc.)16, it is easy to
miss this intermediate and a systematic search for other
FMN-N5-oxide mediated reactions is merited.
ASSOCIATED CONTENT
Supporting Information
Detailed experimental procedures for the syntheses of 4
and 17, DszA and DszB overexpression and purification,
enzymatic assays, and NMR and LC-MS analysis.This ma-
ACS Paragon Plus Environment